Ozempic(semaglutide)

Type 2 diabetes management (GLP-1); FDA-approved.

2 DTP programs

From As little as $25/mo

1 platform

FDA-Approved Indications

Adjunct to diet and exercise for glycemic control in adults with type 2 diabetesReduction of MACE risk in adults with type 2 diabetes and established CVD

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

Savings card (insured)

via NovoCare Pharmacy · Novo Nordisk

As little as $25/mo

$25/mo with commercial insurance. Max $100/mo savings. Good up to 48 months. Does NOT count toward deductible or OOP max.

Eligibility

Valid Rx required. Commercially insured. Government beneficiaries excluded. 48-month limit. Does not count toward deductible or OOP max.

Visit Program

Last verified: Mar 2026

Self-pay cash

via NovoCare Pharmacy · Novo Nordisk

$199–$499/mo

Intro: $199/mo for 0.25mg & 0.5mg (first 2 fills; ends Jun 30 2026). Standard: $349/mo (0.25–1mg), $499/mo (2mg). FSA/HSA accepted.

Eligibility

Valid Rx required. New-patient intro pricing requires being new to Ozempic Savings Offer AND NovoCare Pharmacy. US patient.

Visit Program

Last verified: Mar 2026

Not sure which Ozempic program fits your situation?

Find My Options